Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
T Cell Types and Functions
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pleiotropy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Bart Ferwerda1, Matthew Bb McCall, Karlijn Verheijen
1Department of Internal Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. e.ferwerda@aig.umcn.nl
Toll-like receptor 4 (TLR4) polymorphisms Asp299Gly and Thr399Ile may alter receptor function. This review examines their impact on Gram-negative infections and explores TLR4 genetic variations globally.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: